Smart earbuds that listen to your heart could lull you to sleep

NCT ID NCT07744581

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests a pair of smart earbuds that use artificial intelligence to adjust soothing music in real time based on your heart rate and movement, aiming to help people with chronic insomnia fall asleep faster and sleep deeper. Adults with chronic insomnia will spend three nights in a sleep lab, trying both the AI-adaptive music and standard non-adaptive music, while researchers compare the earbuds' built-in sensors against clinical sleep monitoring equipment. After the lab phase, participants use the earbuds at home for two weeks. The goal is to see if personalized sound therapy can ease insomnia and if a consumer earbud can track sleep as accurately as a hospital system.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-driven neuromodulation music delivered via smart earbuds (NeuroRhythm)
What this could lead to
If effective, this could offer a drug-free, personalized way to treat chronic insomnia and validate consumer earbuds as accurate sleep trackers.
What could go wrong
This is a small early-stage trial (25 people) and results may not apply to everyone. The device's accuracy and effectiveness compared to standard music are still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Longgang Ear, Nose and Throat Hospital

    Shenzhen, Guangdong, 518100, China

  • The Chinese University of Hong Kong Shenzhen

    Shenzhen, Guangdong, 518172, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.